Financials data is unavailable for this security.
View more
Year on year ProMIS Neurosciences Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 18.06m to a smaller loss of 13.21m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -839.15% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, ProMIS Neurosciences Inc increased its cash reserves by 114.41%, or 6.72m. Cash Flow from Financing totalled 17.75m or -- of revenues. In addition the company used 10.84m for operations while cash used for investing totalled 1.35k.
Cash flow per share | -0.6838 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.1201 |
---|---|
Tangible book value per share | -0.1201 |
More ▼
Balance sheet in USDView more
Current ratio | 0.4444 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼